Clinical trial Recruiting at 1 site Observational Ages 18 to 45 Women only

Investigating inflammatory markers in women with PCOS

Official title: Assessment of the Concentrations of Pro- and Anti-inflammatory Cytokines and Their Association With the Metabolic Profile of Women With PCOS

Run by Jagiellonian University · NCT06793085 · Data updated 2026-11-12

This study is testing the levels of certain inflammatory markers in women with polycystic ovary syndrome (PCOS) to see how they compare to women without PCOS and to understand their connection to insulin resistance.

Quick facts

Study typeObservational
Ages18 Years to 45 Years
SexWomen only
Enrollment100 (estimated)
SponsorJagiellonian University
Academic / other
Locations1 site (Krakow)
StatusRecruiting
StartedJanuary 20, 2025
Main results expectedJune 30, 2026
Study endsDecember 31, 2026
Registry record updatedMarch 18, 2026
Trial IDNCT06793085 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are women aged 18-45 years, specifically those with a diagnosis of PCOS.

Probably not a fit

Patients who have had at least one ovary removed, or those with treated diabetes, metabolic diseases, autoimmune diseases, or autoinflammatory diseases may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to measure and compare the levels of pro-inflammatory cytokines (IL-6, TNF-α, IL-18) and the anti-inflammatory cytokine (IL-4) in women with polycystic ovary syndrome (PCOS) and insulin resistance, women with PCOS without carbohydrate metabolism disorders, and a control group of women without PCOS. The study will utilize immunoenzymatic methods (ELISA) and a biochemical analyzer to assess these cytokine concentrations. By identifying the balance of inflammatory markers, the research seeks to uncover potential links to insulin resistance and related health complications in women of reproductive age.

Why it matters

Potential benefit: If successful, this study could lead to improved understanding and identification of biomarkers for insulin resistance in women with PCOS, potentially guiding better treatment strategies.

How similar studies have gone: While there have been studies investigating inflammatory markers in PCOS, this specific approach focusing on the balance of pro- and anti-inflammatory cytokines in relation to insulin resistance is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* women aged 18-45 years

Exclusion Criteria:

* previous removal of at least one ovary
* treated diabetes of any type
* diagnosed and treated metabolic diseases
* diagnosed and treated autoimmune diseases
* diagnosed and treated autoinflammatory diseases

Where it's running

  • Jagiellonian University
    Krakow, Poland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.